Fifth Circuit Upholds Medicare Drug Price Negotiation Program
Appeals court affirms lower court ruling rejecting a challenge by pharmaceutical industry groups.
2 reports on this incident · first at Aug 28, 2026, 2:52 p.m. ET
Earlier reports
Aug 28, 2026, 2:52 p.m. ETFirst report
Court Upholds Medicare Drug Price Negotiation Program
A federal appeals court has upheld the Medicare drug price negotiation program, rejecting a challenge brought by pharmaceutical industry groups. The Fifth Circuit affirmed a lower court decision in a civil case, according to a litigation release reported by Newsweek.
The plaintiffs, including the Pharmaceutical Research and Manufacturers of America (PhRMA), the National Infusion Center Association, and the Global Colon Cancer Association, had argued that the program violated constitutional protections, including due process guarantees and limits on government power. The court's decision was reported by Newsweek.
The case is at the appellate stage and has been adjudicated, with the court ruling against the plaintiffs. The development is part of ongoing legal battles over the program, which allows Medicare to negotiate drug prices.
Was this report accurate and useful?
Sources
Revision history
- Version 128 Aug 2026, 18:52current
First published.
- Version 128 Aug 2026, 18:52current
First published.
How we work
This site models an investigative reporter rather than a wire desk. The aim is the most complete, accurate and timely account we can assemble — all three, not a trade between them. Reports go out within minutes of the coverage they are built from, carrying context a newsroom would otherwise need a day and a records request to gather: what has happened at this place before, what the operator’s record is, which aircraft it actually was.
Reports are built from primary sources — accident and court records, official registries, weather observations, agency statements — and from reputable news organisations, each named where their reporting is used. Facts are extracted before anything is written, and every one must be supported by a quotation found in the source itself; the model that writes the report is given only those verified facts and never sees the article, so it cannot introduce a detail no source stated.
Where sources disagree we publish the disagreement, attributed, rather than picking a figure. Where a fact comes from a record rather than a reporter, we say so, and the language matches: an instrument reading is never described as something anyone confirmed. Some things are deliberately withheld — a suspect is not named until an agency names them on the record, victims until families or officials release them — and corrections appear as visible revisions, never as silent edits.
None of that makes a report true. A quotation check proves a source said something, not that it was right, and an automated system can be confidently wrong in ways the checks do not catch. If something here is wrong, the feedback above is how it gets found. The full methodology, including what we refuse to publish.